Investigator-initiated studies in infectious diseases: considerations for pharmacokinetic-pharmacodynamic optimization

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

92 Downloads (Pure)

Original language	English
Pages (from-to)	1742
Number of pages	1
Journal	Clinical Infectious Diseases
Volume	73
Issue number	9
Early online date	5-May-2021
DOIs	https://doi.org/10.1093/cid/ciab401
Publication status	Published - 1-Nov-2021

Access to Document

@article{e44bf15171074e83aae7953383653062,

title = "Investigator-initiated studies in infectious diseases: considerations for pharmacokinetic-pharmacodynamic optimization",

author = "M{\"a}rtson, {Anne Grete} and Alffenaar, {Jan Willem C.}",

year = "2021",

month = nov,

day = "1",

doi = "10.1093/cid/ciab401",

language = "English",

volume = "73",

pages = "1742",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Investigator-initiated studies in infectious diseases

T2 - considerations for pharmacokinetic-pharmacodynamic optimization

AU - Märtson, Anne Grete

AU - Alffenaar, Jan Willem C.

PY - 2021/11/1

Y1 - 2021/11/1

U2 - 10.1093/cid/ciab401

DO - 10.1093/cid/ciab401

M3 - Comment/Letter to the editor

C2 - 33949643

AN - SCOPUS:85120399266

SN - 1058-4838

VL - 73

SP - 1742

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 9

ER -